SG Americas Securities
TCRT icon

SG Americas Securities’s Alaunos Therapeutics TCRT Stock Holding History

SG Americas Securities’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-226
Closed -$37K – 3417
2021
Q4 		$37K Sell
226
-384
-63% -$84.4K ﹤0.01% 3220
2021
Q3 		$166K Buy
610
+493
+421% +$151K ﹤0.01% 3352
2021
Q2 		$46K Buy
117
+5
+4% +$2.33K ﹤0.01% 2745
2021
Q1 		$60K Sell
112
-3,479
-97% -$2.17M ﹤0.01% 3148
2020
Q4 		$1.36M Sell
3,591
-4,746
-57% -$1.89M 0.01% 1345
2020
Q3 		$3.15M Buy
8,337
+5,048
+153% +$2.23M 0.02% 515
2020
Q2 		$1.62M Buy
3,289
+2,448
+291% +$1.09M 0.01% 980
2020
Q1 		$309K Buy
+841
New +$435K ﹤0.01% 2213
2019
Q3 		– Sell
-2,524
Closed -$2.21M – 3206
2019
Q2 		$2.21M Buy
2,524
+2,311
+1,085% +$1.59M 0.02% 955
2019
Q1 		$123K Buy
213
+50
+31% +$20.9K ﹤0.01% 2915
2018
Q4 		$46K Buy
+163
New +$64.4K ﹤0.01% 2834
2018
Q3 		– Sell
-83
Closed -$38K – 3449
2018
Q2 		$38K Buy
+83
New +$52.6K ﹤0.01% 3206
2017
Q2 		– Sell
-70
Closed -$66K – 3506
2017
Q1 		$66K Sell
70
-69
-50% -$64.2K ﹤0.01% 3075
2016
Q4 		$111K Sell
139
-80
-37% -$72.1K ﹤0.01% 2797
2016
Q3 		$185K Buy
+219
New +$176K ﹤0.01% 2564
2015
Q4 		– Sell
-149
Closed -$201K – 2977
2015
Q3 		$201K Sell
149
-165
-53% -$272K ﹤0.01% 1462
2015
Q2 		$565K Buy
314
+242
+336% +$376K ﹤0.01% 1373
2015
Q1 		$117K Buy
+72
New +$107K ﹤0.01% 2178
2014
Q2 		– Sell
-125
Closed -$86K – 2692
2014
Q1 		$86K Buy
+125
New +$83.7K ﹤0.01% 2246
2013
Q4 		– Sell
-86
Closed -$51K – 2997
2013
Q3 		$51K Sell
86
-68
-44% -$30.6K ﹤0.01% 2793
2013
Q2 		$49K Buy
+154
New +$42.8K ﹤0.01% 2185

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SG Americas Securities's TCRT Position: Q1 2022 in Review

SG Americas Securities sold out of Alaunos Therapeutics (TCRT) in Q1 2022, closing a stake of 226 shares — an estimated $37K sold.

SG Americas Securities first reported a position in TCRT in Q2 2013 and held it in 21 quarters. The position peaked at $3.15M in Q3 2020. 148 funds tracked by Wall St. Rank hold TCRT as of Q1 2022.

  • SG Americas Securities reported no remaining Alaunos Therapeutics position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 226 Alaunos Therapeutics shares in Q1 2022, an estimated $37K.
  • SG Americas Securities first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 21 quarters.
  • SG Americas Securities's Alaunos Therapeutics position peaked at $3.15M in Q3 2020.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.